title: A proposed modification to the Best Pharmaceuticals for Children Act to benefit pediatric oncology.
authors.affiliation: Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, New York 10032, USA. mnn2105@columbia.edu
authors.forename: Michael N
authors.initials: MN
authors.lastname: Needle
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents; D002648:Child; D002675:Child, Preschool; D005062:European Union; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007880:Legislation, Drug; D008297:Male; D008483:Medical Assistance / Q000331:legislation & jurisprudence*; D009369:Neoplasms
chemical_list: D000970:Antineoplastic Agents